Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
APLS | Apellis Pharmaceuticals, Inc. | Director | $50.2 M | -$314 K | -0.62% | Jan 1, 2024 |
Sym | Company | Class | Transaction | % | Value $ | Price $ | Shares | Shares After | Date | Ownership |
---|